Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 257

1.

Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Can Assoc Gastroenterol. 2019 Dec;2(4):149-152. doi: 10.1093/jcag/gwy069. Epub 2019 Feb 1.

2.

PHC Progression Model: a novel mixed-methods tool for measuring primary health care system capacity.

Ratcliffe HL, Schwarz D, Hirschhorn LR, Cejas C, Diallo A, Elorrio EG, Fifield J, Gashumba D, Hartshorn L, Leydon N, Mohamed M, Nakamura Y, Ndiaye Y, Novignon J, Ofosu A, Roder-DeWan S, Rwiyereka A, Secci F, Veillard JH, Bitton A.

BMJ Glob Health. 2019 Sep 13;4(5):e001822. doi: 10.1136/bmjgh-2019-001822. eCollection 2019. Review.

3.

The status of Ghanaian community health workers' supervision and service delivery: descriptive analyses from the 2017 Performance Monitoring and Accountability 2020 survey.

Schwarz D, Kim JH, Ratcliffe H, Bell G, Awoonor-Williams JK, Nimako B, Otupiri E, Lipsitz S, Hirschhorn L, Bitton A.

Version 2. Gates Open Res. 2019 Aug 23 [revised 2019 Jan 1];3:1468. doi: 10.12688/gatesopenres.12979.3. eCollection 2019.

4.

What kind of evidence do we need to strengthen primary healthcare in the 21st century?

Hirschhorn LR, Langlois EV, Bitton A, Ghaffar A.

BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001668. doi: 10.1136/bmjgh-2019-001668. eCollection 2019. No abstract available.

5.

Primary healthcare system performance in low-income and middle-income countries: a scoping review of the evidence from 2010 to 2017.

Bitton A, Fifield J, Ratcliffe H, Karlage A, Wang H, Veillard JH, Schwarz D, Hirschhorn LR.

BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001551. doi: 10.1136/bmjgh-2019-001551. eCollection 2019.

6.

It takes a community: a landscape analysis of global health research consortia.

VanderZanden A, Langlois EV, Ghaffar A, Bitton A, Fifield J, Hirschhorn LR.

BMJ Glob Health. 2019 Aug 16;4(Suppl 8):e001450. doi: 10.1136/bmjgh-2019-001450. eCollection 2019.

7.

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.

Hart L, Chavannes M, Kherad O, Maedler C, Mourad N, Marcus V, Afif W, Bitton A, Lakatos PL, Brassard P, Bessissow T.

J Crohns Colitis. 2019 Jun 10. pii: jjz107. doi: 10.1093/ecco-jcc/jjz107. [Epub ahead of print]

PMID:
31314884
8.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD Research Landscape in Canada.

Rose KL, Sherman PM, Cooke-Lauder J, Mawani M, Benchimol EI, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S81-S91. doi: 10.1093/jcag/gwy057. Epub 2018 Nov 2.

9.

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.

Bernstein CN, Benchimol EI, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S73-S80. doi: 10.1093/jcag/gwy053. Epub 2018 Nov 2.

10.

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors.

Nguyen GC, Targownik LE, Singh H, Benchimol EI, Bitton A, Murthy SK, Bernstein CN, Lee K, Cooke-Lauder J, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S68-S72. doi: 10.1093/jcag/gwy051. Epub 2018 Nov 2.

11.

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.

Carroll MW, Kuenzig ME, Mack DR, Otley AR, Griffiths AM, Kaplan GG, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.

12.

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life.

Jones JL, Nguyen GC, Benchimol EI, Bernstein CN, Bitton A, Kaplan GG, Murthy SK, Lee K, Cooke-Lauder J, Otley AR.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S42-S48. doi: 10.1093/jcag/gwy048. Epub 2018 Nov 2.

13.

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.

Kuenzig ME, Lee L, El-Matary W, Weizman AV, Benchimol EI, Kaplan GG, Nguyen GC, Bernstein CN, Bitton A, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.

14.

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.

Kuenzig ME, Benchimol EI, Lee L, Targownik LE, Singh H, Kaplan GG, Bernstein CN, Bitton A, Nguyen GC, Lee K, Cooke-Lauder J, Murthy SK.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.

15.

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology.

Kaplan GG, Bernstein CN, Coward S, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Benchimol EI.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S6-S16. doi: 10.1093/jcag/gwy054. Epub 2018 Nov 2.

16.

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn's and Colitis Canada.

Benchimol EI, Bernstein CN, Bitton A, Murthy SK, Nguyen GC, Lee K, Cooke-Lauder J, Siddiq S, Windsor JW, Carroll MW, Coward S, El-Matary W, Griffiths AM, Jones JL, Kuenzig ME, Lee L, Mack DR, Mawani M, Otley AR, Singh H, Targownik LE, Weizman AV, Kaplan GG.

J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S1-S5. doi: 10.1093/jcag/gwy052. Epub 2018 Nov 2.

17.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

J Can Assoc Gastroenterol. 2019 Aug;2(3):e1-e34. doi: 10.1093/jcag/gwz019. Epub 2018 Jul 10.

18.

Facility management associated with improved primary health care outcomes in Ghana.

Macarayan EK, Ratcliffe HL, Otupiri E, Hirschhorn LR, Miller K, Lipsitz SR, Gawande AA, Bitton A.

PLoS One. 2019 Jul 2;14(7):e0218662. doi: 10.1371/journal.pone.0218662. eCollection 2019.

19.

Continuity in primary care: a critical but neglected component for achieving high-quality universal health coverage.

Schwarz D, Hirschhorn LR, Kim JH, Ratcliffe HL, Bitton A.

BMJ Glob Health. 2019 May 23;4(3):e001435. doi: 10.1136/bmjgh-2019-001435. eCollection 2019. No abstract available.

20.

Social Norms and Smoking Risk in iTaukei Fijian Adolescent Women.

Gerbasi ME, Gilman SE, Bitton A, Becker AE.

Health Behav Policy Rev. 2019 May;6(3):242-255. doi: 10.14485/HBPR.6.3.4.

PMID:
31157285
21.

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.

Singh K, Al Khoury A, Kurti Z, Gonczi L, Reinglas J, Verdon C, Kohen R, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL.

J Crohns Colitis. 2019 Sep 27;13(10):1343-1350. doi: 10.1093/ecco-jcc/jjz066.

PMID:
30918959
22.

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease.

Chao CY, Lemieux C, Restellini S, Afif W, Bitton A, Lakatos PL, Wild G, Bessissow T.

Saudi J Gastroenterol. 2019 May-Jun;25(3):159-166. doi: 10.4103/sjg.SJG_566_18.

23.

Risk of Malignant Cancers in Inflammatory Bowel Disease.

Loo SY, Vutcovici M, Bitton A, Lakatos PL, Azoulay L, Suissa S, Brassard P.

J Crohns Colitis. 2019 Sep 27;13(10):1302-1310. doi: 10.1093/ecco-jcc/jjz058.

PMID:
30874294
24.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Panaccione R, Steinhart AH, Bressler B, Khanna R, Marshall JK, Targownik L, Afif W, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C, Bernstein CN.

Clin Gastroenterol Hepatol. 2019 Aug;17(9):1680-1713. doi: 10.1016/j.cgh.2019.02.043. Epub 2019 Mar 7.

PMID:
30853616
25.

90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin's Lymphoma.

Hernandez R, Walker KL, Grudzinski JJ, Aluicio-Sarduy E, Patel R, Zahm CD, Pinchuk AN, Massey CF, Bitton AN, Brown RJ, Sondel PM, Morris ZS, Engle JW, Capitini CM, Weichert JP.

Commun Biol. 2019 Feb 26;2:79. doi: 10.1038/s42003-019-0327-4. eCollection 2019.

26.

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.

Gonczi L, Kurti Z, Verdon C, Reinglas J, Kohen R, Morin I, Chavez K, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL.

J Crohns Colitis. 2019 Sep 19;13(9):1138-1147. doi: 10.1093/ecco-jcc/jjz035.

PMID:
30793162
27.

A Cross-Sectional Study on Malnutrition in Inflammatory Bowel Disease: Is There a Difference Based on Pediatric or Adult Age Grouping?

Marcil V, Levy E, Amre D, Bitton A, Sant'Anna AMGA, Szilagy A, Sinnett D, Seidman EG.

Inflamm Bowel Dis. 2019 Jul 17;25(8):1428-1441. doi: 10.1093/ibd/izy403.

PMID:
30793155
28.

Association of Primary Care Physician Supply With Population Mortality in the United States, 2005-2015.

Basu S, Berkowitz SA, Phillips RL, Bitton A, Landon BE, Phillips RS.

JAMA Intern Med. 2019 Apr 1;179(4):506-514. doi: 10.1001/jamainternmed.2018.7624.

PMID:
30776056
29.

Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures.

Noiseux I, Veilleux S, Bitton A, Kohen R, Vachon L, White Guay B, Rioux JD.

BMC Gastroenterol. 2019 Feb 13;19(1):30. doi: 10.1186/s12876-019-0946-8.

30.

Health Care Spending Slowed After Rhode Island Applied Affordability Standards To Commercial Insurers.

Baum A, Song Z, Landon BE, Phillips RS, Bitton A, Basu S.

Health Aff (Millwood). 2019 Feb;38(2):237-245. doi: 10.1377/hlthaff.2018.05164.

PMID:
30715981
31.

Vaccination Guidelines for Patients with Immune-mediated Disorders Taking Immunosuppressive Therapies: Executive Summary.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Rheumatol. 2019 Jul;46(7):751-754. doi: 10.3899/jrheum.180784. Epub 2019 Feb 1.

32.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Apr;156(5):1345-1353.e4. doi: 10.1053/j.gastro.2019.01.002. Epub 2019 Jan 10.

33.

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic.

Reinglas J, Restellini S, Gonczi L, Kurti Z, Verdon C, Nene S, Kohen R, Afif W, Bessissow T, Wild G, Seidman E, Bitton A, Lakatos PL.

Dig Liver Dis. 2019 Mar;51(3):340-345. doi: 10.1016/j.dld.2018.11.013. Epub 2018 Dec 3.

PMID:
30591367
34.

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review.

Restellini S, Chao CY, Martel M, Barkun A, Kherad O, Seidman E, Wild G, Bitton A, Afif W, Bessissow T, Lakatos PL.

Clin Gastroenterol Hepatol. 2019 Jun;17(7):1265-1275.e8. doi: 10.1016/j.cgh.2018.12.021. Epub 2018 Dec 21. Review.

PMID:
30583048
35.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

36.

Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, Bressler B, Gooderham M, Ho V, Jamal S, Pope JE, Steinhart AH, Vinh DC, Wade J.

J Cutan Med Surg. 2019 Jan/Feb;23(1):50-74. doi: 10.1177/1203475418811335. Epub 2018 Nov 21.

37.

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.

Chao CY, Al Khoury A, Aruljothy A, Restellini S, Wyse J, Afif W, Bitton A, Lakatos PL, Bessissow T.

Dig Dis Sci. 2019 Feb;64(2):518-523. doi: 10.1007/s10620-018-5358-z. Epub 2018 Nov 16.

PMID:
30446928
38.

Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'.

Balram B, Battat R, Al-Khoury A, D'Aoust J, Afif W, Bitton A, Lakatos PL, Bessissow T.

J Crohns Colitis. 2019 Mar 30;13(4):536-537. doi: 10.1093/ecco-jcc/jjy176. No abstract available.

PMID:
30371761
39.

Gatekeeping and patterns of outpatient care post healthcare reform.

Barnett ML, Song Z, Bitton A, Rose S, Landon BE.

Am J Manag Care. 2018 Oct 1;24(10):e312-e318.

40.

The 5S-5M-5C schematic: transforming primary care inputs to outcomes in low-income and middle-income countries.

Bitton A, Veillard JH, Basu L, Ratcliffe HL, Schwarz D, Hirschhorn LR.

BMJ Glob Health. 2018 Oct 2;3(Suppl 3):e001020. doi: 10.1136/bmjgh-2018-001020. eCollection 2018. No abstract available.

41.

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.

Côté-Daigneault J, Bessissow T, Nicolae MV, Nie R, Bitton A, Lakatos PL, Brassard P.

Inflamm Bowel Dis. 2019 Apr 11;25(5):914-918. doi: 10.1093/ibd/izy311.

PMID:
30295818
42.

Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Balram B, Battat R, Al-Khoury A, D'Aoust J, Afif W, Bitton A, Lakatos PL, Bessissow T.

J Crohns Colitis. 2019 Jan 1;13(1):27-38. doi: 10.1093/ecco-jcc/jjy143.

PMID:
30247650
43.

Adverse Events and Resource Use Before and After Treat-to-Target in Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.

Solomon DH, Yu Z, Katz JN, Bitton A, Corrigan C, Fraenkel L, Harrold LR, Smolen JS, Losina E, Lu B.

Arthritis Care Res (Hoboken). 2019 Sep;71(9):1243-1248. doi: 10.1002/acr.23755. Epub 2019 Jul 19.

PMID:
30221841
44.

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.

Bitton A, Vutcovici M, Lytvyak E, Kachan N, Bressler B, Jones J, Lakatos PL, Sewitch M, El-Matary W, Melmed G, Nguyen G; QI consensus group; Promoting Access and Care through Centers of Excellence-PACE program).

Inflamm Bowel Dis. 2019 Jan 10;25(2):403-409. doi: 10.1093/ibd/izy259.

PMID:
30169582
45.

Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn's Disease: The Toronto Consensus.

Steinhart AH, Panaccione R, Targownik L, Bressler B, Khanna R, Marshall JK, Afif W, Bernstein CN, Bitton A, Borgaonkar M, Chauhan U, Halloran B, Jones J, Kennedy E, Leontiadis GI, Loftus EV Jr, Meddings J, Moayyedi P, Murthy S, Plamondon S, Rosenfeld G, Schwartz D, Seow CH, Williams C.

Inflamm Bowel Dis. 2019 Jan 1;25(1):1-13. doi: 10.1093/ibd/izy247.

PMID:
30099529
46.

Finance and Time Use Implications of Team Documentation for Primary Care: A Microsimulation.

Basu S, Phillips RS, Bitton A, Song Z, Landon BE.

Ann Fam Med. 2018 Jul;16(4):308-313. doi: 10.1370/afm.2247.

47.

Barriers to treatment adjustment within a treat to target strategy in rheumatoid arthritis: a secondary analysis of the TRACTION trial.

Zak A, Corrigan C, Yu Z, Bitton A, Fraenkel L, Harrold L, Smolen JS, Solomon DH.

Rheumatology (Oxford). 2018 Nov 1;57(11):1933-1937. doi: 10.1093/rheumatology/key179.

PMID:
29982720
48.

A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.

Al-Taweel T, Strohl M, Pai M, Martel M, Bessissow T, Bitton A, Seidman E, Afif W.

Dig Dis Sci. 2018 Oct;63(10):2695-2702. doi: 10.1007/s10620-018-5178-1. Epub 2018 Jul 3.

PMID:
29968143
49.

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.

Shah SC, Khalili H, Gower-Rousseau C, Olen O, Benchimol EI, Lynge E, Nielsen KR, Brassard P, Vutcovici M, Bitton A, Bernstein CN, Leddin D, Tamim H, Stefansson T, Loftus EV Jr, Moum B, Tang W, Ng SC, Gearry R, Sincic B, Bell S, Sands BE, Lakatos PL, Végh Z, Ott C, Kaplan GG, Burisch J, Colombel JF.

Gastroenterology. 2018 Oct;155(4):1079-1089.e3. doi: 10.1053/j.gastro.2018.06.043. Epub 2018 Jun 27.

PMID:
29958857
50.

Does quality influence utilization of primary health care? Evidence from Haiti.

Gage AD, Leslie HH, Bitton A, Jerome JG, Joseph JP, Thermidor R, Kruk ME.

Global Health. 2018 Jun 20;14(1):59. doi: 10.1186/s12992-018-0379-0.

Supplemental Content

Loading ...
Support Center